Trials / Completed
CompletedNCT02419352
Sugammadex and Cognitive Function
Effect of Sugammadex Versus Neostigmine/Atropine Combination on Cognitive Function After Elective Adult Surgery
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 160 (actual)
- Sponsor
- Attikon Hospital · Academic / Other
- Sex
- All
- Age
- 40 Years
- Healthy volunteers
- Accepted
Summary
Post operative cognitive dysfunction (POCD) is recognized as a frequent complication after both cardiac and non cardiac surgery, affecting approximately 1/3 of the patients. The aim of this study is to examine the possible effect of the novel reversal agent sugammadex versus neostigmine/ atropine combination on cognitive function of adult patients after elective surgery during the early post operative period as well as at discharge.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Sugammadex | |
| DRUG | Neostigmine/atropine |
Timeline
- Start date
- 2010-09-01
- Primary completion
- 2015-12-01
- Completion
- 2015-12-01
- First posted
- 2015-04-17
- Last updated
- 2020-04-13
Locations
1 site across 1 country: Greece
Source: ClinicalTrials.gov record NCT02419352. Inclusion in this directory is not an endorsement.